E-DRUG: Therapeutics Letter #62: Mild Hypertension
----------------------------------------------
NEW: THERAPEUTICS LETTER #62(Jan-Feb 2007): "Mild Hypertension":
http://www.ti.ubc.ca/pages/letter62.htm
I would like to bring to your attention the latest issue (#62) of the Therapeutics Letter: "Mild Hypertension: An approach to using evidence in the decision making process" that has just been posted on the Therapeutics Initiative web site at
http://www.ti.ubc.ca/pages/letter62.htm
We think health care professionals should try to practice evidence based medicine and share informed decision making whenever possible. In this Letter we use a fictitious case which illustrates a common presentation in family practice and describe an attempt to approach it using the principles of evidence developed by the Cochrane Collaboration. We conclude that using the best available evidence, the magnitude of benefit for drug treatment of mild hypertension can be estimated and presented to a patient; that shared-informed decision making can only truly be done if one can provide reasonable estimates of the potential benefits and harms of a proposed therapy; and that RCTs are needed to test whether using this evidence and shared-informed decision making approach changes mortality and morbidity as compared to usual care.
I invite you to drop by and have a look at this Letter. Please feel free to forward this message to any of your friends or colleagues that might be interested in this topic.
We would appreciate receiving your comments on this Therapeutics Letter and its possible implications in clinical practice.
Regards,
Ciprian Jauca
Manager
Therapeutics Initiative
University of British Columbia
Department of Anesthesiology, Pharmacology & Therapeutics
2176 Health Sciences Mall
Vancouver, BC V6T 1Z3
Canada
Email: jauca@ti.ubc.ca
Tel: +1-604-822-0700
Fax: +1-604-822-0701
Web: www.ti.ubc.ca
"Ciprian Jauca" <jauca@ti.ubc.ca>